Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emblation is a medical technology company specializing in the development of portable microwave systems for applications in dermatology, podiatry, and oncology. The company's flagship product, Swift, is a non-invasive microwave treatment for skin lesions such as warts and verrucae, which has seen significant global adoption. Beyond dermatology, Emblation is expanding its technology platform into the fields of cardiology and oncology to treat various forms of cancer. Headquartered in Scotland, the company focuses on providing precise, controlled thermal energy to trigger immune responses and tissue ablation. Their technology aims to replace more invasive or less effective traditional treatments like cryotherapy or electrosurgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emblation.